BCG vaccination in low birth weight newborns: analysis of lymphocyte proliferation, IL-2 generation and intradermal reaction to PPD

Tuber Lung Dis. 1996 Oct;77(5):476-81. doi: 10.1016/s0962-8479(96)90123-9.

Abstract

Objective: To study vaccinal scar formation and post-vaccinal immune response in newborns with birth weight ranging from 2000 to 2499 g vaccinated in the first week of life with intradermal bacille Calmette-Guérin (BCG) (Moreau-Rio de Janeiro strain).

Method: Specific immune response to PPD was assessed in 30 low birth weight newborns (mean birth weight = 2311.7 +/- 122.1 g; mean gestational age = 38.1 +/- 1.8 weeks) in comparison to 56 control infants (mean birth weight = 3198.9 +/- 267.2 g; mean gestational age = 38.5 +/- 1.2 weeks.

Results: Low birth weight infants have an efficient immune response to vaccinal stimulus when compared to control infants as judged by specific in vitro lymphocyte proliferation (mean SI = 9.7 +/- 12.9 vs SI = 8.8 +/- 10.0, P = 0.72) and IL-2 production (mean SI = 3.1 +/- 3.4 vs SI = 2.6 +/- 2.0, P = 0.38). Intradermal reaction to PPD was also comparable in both groups (mean induration diameter = 9.5 +/- 5.1 mm vs 9.6 +/- 5.0 mm, P = 0.94).

Conclusion: These data suggest that low birth weight newborns show a good immune response to BCG, thus reinforcing the inclusion of such infants in regular vaccination programs with intradermal BCG.

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • BCG Vaccine / immunology*
  • Cell Culture Techniques
  • Cell Division / immunology
  • Cicatrix / pathology
  • Female
  • Humans
  • Immunity, Cellular
  • Infant, Low Birth Weight / immunology*
  • Infant, Newborn
  • Interleukin-2 / biosynthesis*
  • Lymph Nodes / immunology
  • Lymphocytes / immunology*
  • Male
  • Prospective Studies
  • Tuberculin Test

Substances

  • BCG Vaccine
  • Interleukin-2